F

    Fresenius Medical Care Corporation (FMS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $22.73
    -0.37 (-1.60%)

    Market Cap: $12.29B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    63%(26/41)
    Avg Surprise
    +6.71%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.50
    Range$0.46 - $0.55
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.57+12.7%
    60d ago$0.57+12.7%
    30d ago$0.56+12.0%
    7d ago$0.50+0.0%
    Current$0.50
    Revenue Consensus
    $5.0B
    Range$4.9B - $5.1B
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.57
    Range$0.43 - $0.72
    4 analysts
    Revenue Consensus
    $5.2B
    Range$4.8B - $6.4B
    17 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.57---
    Sep 26EST
    		-$0.50---
    Jun 26
    Reported Aug 3
    		$0.66$0.50+32.00%Beat+43.5%
    Mar 26
    Reported May 5
    		$0.46$0.53-13.58%Miss+8.3%
    Dec 25
    Reported Feb 24
    		$0.72$0.55+30.91%Beat+58.2%
    Sep 25
    Reported Nov 4
    		$0.55$0.50+10.00%Beat+34.1%
    Jun 25
    Reported Aug 5
    		$0.46$0.47-2.13%Miss+31.4%
    Mar 25
    Reported May 6
    		$0.42$0.38+10.53%Beat+31.2%
    Dec 24
    Reported Feb 25
    		$0.46$0.40+13.61%Beat+3.4%
    Sep 24
    Reported Nov 5
    		$0.41$0.35+17.14%Beat+46.4%
    Jun 24
    Reported Jul 30
    		$0.35$0.34+2.94%Beat+16.7%
    Mar 24
    Reported May 7
    		$0.32$0.25+28.00%Beat+23.1%
    Dec 23
    Reported Feb 20
    		$0.44$0.30+46.67%Beat+83.3%
    Sep 23
    Reported Nov 1
    		$0.28$0.31-9.68%Miss+33.3%
    Jun 23
    Reported Aug 2
    		$0.30$0.28+7.14%Beat-23.1%
    Mar 23
    Reported May 9
    		$0.26$0.12+116.67%Beat-23.5%
    Dec 22
    Reported Feb 21
    		$0.24$0.22+9.09%Beat-38.5%
    Sep 22
    Reported Oct 30
    		$0.21$0.34-38.24%Miss-55.3%
    Jun 22
    Reported Jul 28
    		$0.39$0.43-9.30%Miss+2.6%
    Mar 22
    Reported May 4
    		$0.34$0.26+30.77%Beat-20.9%
    Dec 21
    Reported Feb 22
    		$0.39$0.43-9.30%Miss-39.1%
    Sep 21
    Reported Nov 2
    		$0.47$0.44+6.82%Beat-23.0%
    Jun 21
    Reported Jul 30
    		$0.38$0.43-11.63%Miss-36.7%
    Mar 21
    Reported May 6
    		$0.43$0.38+13.16%Beat-8.5%
    Dec 20
    Reported Feb 23
    		$0.64$0.64+0.00%Beat-5.9%
    Sep 20
    Reported Oct 29
    		$0.61$0.54+12.96%Beat+10.9%
    Jun 20
    Reported Jul 30
    		$0.60$0.50+20.00%Beat+30.4%
    Mar 20
    Reported May 6
    		$0.47$0.60-21.67%Miss-9.6%
    Dec 19
    Reported Feb 20
    		$0.68$0.63+7.94%Beat+19.3%
    Sep 19
    Reported Oct 29
    		$0.55$0.56-1.79%Miss+7.8%
    Jun 19
    Reported Jul 30
    		$0.46$0.49-6.12%Miss+2.2%
    Mar 19
    Reported May 2
    		$0.52$0.48+8.33%Beat+30.0%
    Dec 18
    Reported Feb 20
    		$0.57$0.57+0.00%Beat-16.2%
    Sep 18
    Reported Oct 30
    		$0.51$0.56-8.93%Miss-1.9%
    Jun 18
    Reported Jul 31
    		$0.45$0.53-15.09%Miss+0.0%
    Mar 18
    Reported May 3
    		$0.40$0.55-27.27%Miss-24.5%
    Dec 17
    Reported Feb 26
    		$0.68$0.70-2.86%Miss+65.9%
    Sep 17
    Reported Nov 2
    		$0.52$0.52+0.00%Beat-18.8%
    Jun 17
    Reported Aug 1
    		$0.45$0.46-2.17%Miss-10.0%
    Apr 17
    Reported May 3
    		$0.53$0.44+20.45%Beat-
    Mar 17
    Reported May 3
    		$0.41$0.41+0.00%Beat-
    Dec 16
    Reported Feb 22
    		$0.64$0.62+3.23%Beat-
    Sep 16
    Reported Oct 27
    		$0.50$0.47+6.38%Beat-

    Dividends

    Dividend Metrics

    Yield3.83%
    Annual/Share$0.87
    Payout Ratio43.05%
    Frequency1
    Pay MonthsJun

    Growth

    3Y CAGR+4.74%
    5Y CAGR+2.88%
    View FMS's full dividend history

    Key Metrics

    Valuation
    P/E Ratio9.53EV/EBITDA5.85x
    Price/FCF5.96xFCF Yield16.79%
    Profitability
    Profit Margin4.83%Operating Margin10.80%
    ROE8.52%ROIC7.48%
    Financial Health
    Debt/Equity0.60xInterest Coverage4.89x
    Current Ratio1.07xQuick Ratio0.75x
    Trading Statistics
    Beta0.84Avg Volume804.24K
    52-Week High$26.5752-Week Low$19.24

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$23.38
    SMA 20$23.65
    SMA 50$23.91
    SMA 200$22.70
    EMA 10$23.33
    EMA 20$23.60
    EMA 50$23.59
    EMA 200$23.27

    MACD

    Line: -0.27Signal: -0.16Hist: -0.11

    ADX

    ADX: 13.3+DI: 18.8-DI: 30.5

    Aroon & PSAR

    Aroon Up20.0
    Aroon Down100.0
    PSAR$24.46

    Bollinger Bands

    Upper Band$24.42
    Lower Band$22.87
    %B Position659%(Upper)
    Band Width-0.09

    RSI (14-Day)

    Neutral
    33.2

    Momentum Oscillators

    Stoch %K9.0
    Stoch %D11.0
    Williams %R-97.8
    ROC (10d)-3.3%
    Momentum-0.77
    CCI (20d)-204.9
    MFI (14d)40.6

    Volatility Measures

    ATR (14d)$0.42(1.9%)
    StdDev (20d)0.39
    Hist Vol21.6%(Moderate)

    Volume Flow

    VWAP$22.77
    OBV-96.0K
    AD Line-390.2M
    CMF (20d)-0.160

    Volume Metrics

    Avg Vol (20d)772.9K
    Vol Ratio0.8x
    VWMA (20d)$23.70

    Pivot Points

    R3$23.59
    R2$23.41
    R1$23.26
    Pivot Point$23.08
    S1$22.93
    S2$22.75
    S3$22.60

    Advanced Oscillators

    TSI-16.17
    Ultimate Osc39.7
    KST-35.20

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$4.86B$4.61B$5.07B$4.88B$4.79B$4.88B$5.08B$4.76B$4.77B$4.72B$4.99B$4.94B
    Cost of Revenue$3.55B$3.43B$3.68B$3.64B$3.58B$3.70B$3.81B$3.61B$3.60B$3.55B$3.64B$3.71B
    Gross Profit$1.31B$1.18B$1.39B$1.24B$1.21B$1.18B$1.27B$1.15B$1.17B$1.17B$1.35B$1.23B
    Operating Expenses$844.13M$803.94M$839.39M$740.50M$819.96M$802.25M$871.49M$683.39M$741.00M$927.64M$922.01M$905.00M
    R&D$39.63M$38.31M$38.63M$37.75M$38.12M$43.48M$50.06M$40.05M$46.00M$47.80M$65.98M$53.00M
    SG&A$736.01M$601.40M$727.35M$519.32M$607.73M$594.20M$644.89M$555.82M$580.03M$585.08M$845.16M$591.74M
    Operating Income$465.86M$375.56M$548.98M$501.72M$394.40M$381.73M$398.93M$462.70M$425.00M$246.01M$427.65M$324.00M
    Interest Income$14.70M$14.62M$13.62M$19.16M$21.85M$14.98M$21.57M$16.93M$18.00M$15.66M$26.87M$25.14M
    Interest Expense$97.55M$93.30M$99.02M$93.10M$96.58M$95.72M$101.04M$99.00M$103.00M$103.85M$111.46M$114.00M
    Income Before Tax$383.00M$207.52M$508.46M$402.57M$350.55M$250.65M$179.12M$380.53M$340.00M$157.83M$343.06M$235.00M
    Income Tax Expense$89.83M$42.75M$106.44M$75.22M$78.26M$61.05M$61.00M$116.53M$99.00M$39.51M$86.46M$88.00M
    Net Income$218.38M$117.53M$327.08M$274.80M$225.27M$151.22M$66.90M$213.03M$187.00M$70.96M$187.93M$84.00M
    EBITDA$823.01M$763.76M$981.03M$852.92M$822.37M$740.73M$757.13M$845.89M$830.00M$774.12M$880.45M$803.00M
    EBIT$465.86M$300.82M$607.48M$495.66M$447.13M$346.37M$280.13M$479.63M$443.00M$261.68M$454.51M$349.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about FMS

    News

    Fresenius Medical Care Aktie kaufen oder verkaufen: Analystenbewertungen im August `26

    The article summarizes analyst ratings for Fresenius Medical Care (FME) stock in August 2026. A majority of analysts recommend selling the stock, with 7 advising a sell, 5 a hold, and only 1 a buy. The average price target is €37.17, indicating a potential downside of -5.56%.

    Wallstreet Online•9/1/26•
    Somewhat-Bearish

    Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Given Consensus Rating of "Reduce" by Brokerages

    Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has received a consensus "Reduce" rating from eleven brokerages, with an average 12-month price target of $23.57, which is close to its current price of $23.07. Despite mixed analyst actions including an upgrade by Bernstein and a downgrade by BNP Paribas Exane, the company surpassed quarterly expectations with $0.66 EPS and $5.55 billion in revenue. Institutional investors hold 8.37% of the stock, with several major funds increasing their positions.

    MarketBeat•8/31/26•
    Somewhat-Bearish

    Fresenius Medical Care (FMC) St-Aktie: GD 200 nach oben gekreuzt im Fresenius Medical Care (FMC) St-Chart

    The Fresenius Medical Care (FMC) St. stock recently experienced a "GD 100 crossed downwards" chart signal on August 31, 2026, indicating a down signal. The stock was trading down 0.2 percent at 39.38 EUR in XETRA. Fresenius Medical Care AG & Co. KGaA is a leading global provider of products and services for dialysis technology, treating chronic kidney failure.

    Finanzen.net•8/26/26•
    Somewhat-Bearish

    Fresenius Medical Care stock steadies as parent’s €309 million stake sale sets new price benchma

    Fresenius Medical Care AG stock is trading stably in the low €40 range after its parent company sold 7.8 million shares to J.P. Morgan SE for €309 million at €39.56 per share. This secondary placement provides a new valuation benchmark, with the market price remaining slightly above the deal level. The transaction preserves the parent company's substantial holding and highlights Fresenius Medical Care's continued focus on its core dialysis business.

    Ad-hoc-news.de•8/25/26•
    Somewhat-Bullish

    Major Fresenius Medical Care (NYSE: FMS) investor moves to sell block of shares

    Fresenius SE & Co. KGaA, a major shareholder in Fresenius Medical Care AG (FMS), has agreed to sell 7.8 million shares in a block trade to J.P. Morgan SE for EUR 39.56 per share. This transaction, expected to close on August 25, 2026, is part of Fresenius KGaA's portfolio optimization strategy, reducing its beneficial ownership to approximately 25.6% of FMS voting shares. A 45-day lock-up period prevents further sales without J.P. Morgan SE's consent.

    Stock Titan•8/24/26•
    Neutral

    Frequently Asked Questions About FMS

    What is FMS's current dividend yield?
    Fresenius Medical Care Corporation (FMS) has a current dividend yield of 3.83%.
    Does FMS pay dividends?
    Yes, Fresenius Medical Care Corporation pays dividends with a current yield of 3.83%.
    What is FMS's P/E ratio?
    Fresenius Medical Care Corporation has a price-to-earnings (P/E) ratio of 9.53.
    What is FMS's market cap?
    Fresenius Medical Care Corporation (FMS) has a market capitalization of $12.29B with a current stock price of $22.73.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In